Shoulder Innovations, Inc. (SI)

NYSE: SI · Real-Time Price · USD
14.96
+0.14 (0.94%)
At close: Apr 10, 2026, 4:00 PM EDT
14.96
0.00 (0.00%)
After-hours: Apr 10, 2026, 7:00 PM EDT
Market Cap308.89M
Revenue (ttm)47.32M +49.6%
Net Income-40.36M
EPS-4.65
Shares Out 20.65M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume13,461
Open14.83
Previous Close14.82
Day's Range14.78 - 14.96
52-Week Range10.92 - 17.94
Betan/a
AnalystsStrong Buy
Price Target20.80 (+39.04%)
Earnings DateMay 10, 2026

About SI

Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant systems for shoulder arthroplasty in the United States. It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion. The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan.

Industry Medical - Specialties
Sector Healthcare
IPO Date Jul 31, 2025
Employees 75
Stock Exchange NYSE
Ticker Symbol SI
Full Company Profile

Financial Performance

In 2025, Shoulder Innovations's revenue was $47.32 million, an increase of 49.63% compared to the previous year's $31.62 million. Losses were -$40.36 million, 158.4% more than in 2024.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for SI stock is "Strong Buy." The 12-month stock price target is $20.8, which is an increase of 39.04% from the latest price.

Price Target
$20.8
(39.04% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Shoulder surgery-focused medtech Shoulder Innovations files for a $100 million IPO

Shoulder Innovations, which offers advanced implant systems for shoulder arthroplasty, filed on Monday with the SEC to raise up to $100 million in an initial public offering.

9 months ago - Renaissance Capital

Shoulder Innovations IPO Registration Document (S-1)

Shoulder Innovations has filed to go public with an IPO on the New York Stock Exchange (NYSE).

9 months ago - SEC